Lyell Immunopharma shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $179k | 92k | 1.94 |
| 2023-09-30 | $135k | 92k | 1.47 |
| 2023-06-30 | $293k | 92k | 3.18 |
| 2023-03-31 | $177k | 75k | 2.36 |
| 2022-12-31 | $321k | 93k | 3.47 |
| 2022-09-30 | $678k | 93k | 7.33 |
| 2022-06-30 | $603k | 93k | 6.52 |
| 2022-03-31 | $427k | 85k | 5.05 |
| 2021-09-30 | $153k | 10k | 14.80 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors